Search results
Showing 1336 to 1350 of 1516 results for patients and public
In development Reference number: GID-TA11697 Expected publication date: TBC
In development Reference number: GID-TA11627 Expected publication date: TBC
In development Reference number: GID-TA11482 Expected publication date: TBC
Oral semaglutide for managing overweight and obesity [ID6188]
Discontinued Reference number: GID-TA11149
Etripamil for treating paroxysmal supraventricular tachycardia [ID6581]
In development Reference number: GID-TA11750 Expected publication date: TBC
In development Reference number: GID-MT591 Expected publication date: TBC
Dupilumab for treating chronic spontaneous urticaria in people 12 years and over [ID4055]
In development Reference number: GID-TA11272 Expected publication date: TBC
In development Reference number: GID-TA11274 Expected publication date: TBC
Discontinued Reference number: GID-TA11171
Capecitabine for the treatment of advanced pancreatic cancer [ID127]
Discontinued Reference number: GID-TA11239
Discontinued Reference number: GID-TA11258
In development Reference number: GID-TA11588 Expected publication date: TBC
In development Reference number: GID-TA11771 Expected publication date: TBC
Govorestat for treating classic galactosemia in people 2 to 65 years [TSID12071]
In development Reference number: GID-TA11634 Expected publication date: TBC
In development Reference number: GID-TA11327 Expected publication date: TBC